Jump to main content
Jump to site search

Issue 1, 2014
Previous Article Next Article

Identification and optimisation of 3,3-dimethyl-azetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

Author affiliations

Abstract

3,3-Di-methyl-azetidin-2-ones were identified as potent and selective 11β-HSD1 inhibitors against the human and mouse forms of the enzyme. Structure guided optimisation of LLE was conducted, utilising a key polar interaction and identifying stereochemical preference for the 4S isomer. Metabolic stability was improved to afford oral exposure, providing tool compounds suitable for pre-clinical evaluation.

Graphical abstract: Identification and optimisation of 3,3-dimethyl-azetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 21 Aug 2013, accepted on 04 Nov 2013 and first published on 06 Nov 2013


Article type: Concise Article
DOI: 10.1039/C3MD00234A
Citation: Med. Chem. Commun., 2014,5, 57-63
  •   Request permissions

    Identification and optimisation of 3,3-dimethyl-azetidin-2-ones as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)

    W. McCoull, M. Augustin, C. Blake, A. Ertan, E. Kilgour, S. Krapp, J. E. Moore, N. J. Newcombe, M. J. Packer, A. Rees, J. Revill, J. S. Scott, N. Selmi, S. Gerhardt, D. J. Ogg, S. Steinbacher and P. R. O. Whittamore, Med. Chem. Commun., 2014, 5, 57
    DOI: 10.1039/C3MD00234A

Search articles by author